Utilizes artificial intelligence and whole genome sequencing to detect unique patterns of DNA fragmentation in the blood of cancer patients.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
Delfi Diagnostics Funding
Sign up to gain insights into Delfi Diagnostics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | Jul 18, 2022 | 225M | ||
| Series A | Jan 12, 2021 | 96M | ||
| Seed | Aug 12, 2019 | 5M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Delfi Diagnostics Management Team
Investors
AV8 Ventures
Brown Advisory
Cowen Healthcare Investments
DFJ Growth
Eli Lilly & Company
Foresite Capital
Illumina, Inc.
Initiate Ventures
Menlo Ventures
Merck Global Health Innovation Fund
Northpond Ventures
Open Field Capital LLC
OrbiMed Advisors LLC
Osage University Partners
Point72 Ventures
Point Field Partners
PTX Capital
Rock Springs Capital
Samsara BioCapital
T. Rowe Price Associates, Inc.
Windham Venture Partners
Delfi Diagnostics Valuations & Financials
View real-time NPM data on Delfi Diagnostics stock including daily Delfi Diagnostics stock price estimates, valuation history, and historical share price information. Access Delfi Diagnostics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Delfi Diagnostics pricing across six independent market signals. Looking for private company due diligence data sources on Delfi Diagnostics? Get in touch to learn more.
Similar Companies
like Delfi Diagnostics
Clipboard Health
Healthcare & Life Sciences
Uses technology to help nursing facilities get the right nurse at the right place at the right time.
Devoted Health
Healthcare & Life Sciences
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Capstan Medical
Healthcare & Life Sciences
Merges surgical robotics with catheter-based technology to repair and replace heart valves.
Loyal
Healthcare & Life Sciences
Develops therapies to treat the underlying causes of aging in dogs.
Hone Health
Healthcare & Life Sciences
Online clinic specializing in preventative and proactive longevity care.
Clear Labs
Healthcare & Life Sciences
Pioneers in food analytics, enabling brands to differentiate on quality and ensure value.
FAQ
We have answers
Delfi Diagnostics stock does not trade on public stock exchanges. Delfi Diagnostics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Delfi Diagnostics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Delfi Diagnostics Stock does not trade on public stock exchanges. In order to sell Delfi Diagnostics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Delfi Diagnostics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Delfi Diagnostics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Delfi Diagnostics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Delfi Diagnostics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Delfi Diagnostics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Delfi Diagnostics is a private company and has not had an IPO. There is currently no Delfi Diagnostics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Delfi Diagnostics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
